Stephen Collingwood

Title: The Innovations of Stephen Collingwood

Introduction

Stephen Collingwood is a notable inventor based in Haywards Heath, GB. He has made significant contributions to the field of respiratory disease treatment through his innovative work. With a total of 4 patents, Collingwood is recognized for his advancements in medical compounds that target specific channels in the body.

Latest Patents

Collingwood's latest patents focus on modulators of TMEM16A, which are crucial for treating respiratory diseases. One of his key inventions includes compounds of general formula (I), wherein R, R, R, R, A, Z, Z, and Y are defined for their utility in treating respiratory diseases and other conditions modulated by TMEM16A. Another significant patent involves compounds that act as positive modulators of the calcium-activated chloride channel (CaCC), TMEM16A. These compounds are particularly useful for addressing diseases and conditions affected by the modulation of TMEM16A.

Career Highlights

Collingwood's career is marked by his dedication to research and innovation in the medical field. His work has led to the development of groundbreaking treatments that have the potential to improve the quality of life for individuals suffering from respiratory conditions. He is currently associated with Tmem16a Limited, where he continues to advance his research.

Collaborations

Some of his notable coworkers include Jonathan David Hargrave and Duncan Alexander Hay. Their collaborative efforts contribute to the innovative environment at Tmem16a Limited.

Conclusion

Stephen Collingwood's contributions to the field of respiratory disease treatment through his patents and research are commendable. His work exemplifies the impact of innovation in medicine, and his ongoing efforts promise to lead to further advancements in the future.